The evolution of self-reported urinary and sexual dysfunction over the last two decades: Implications for comparative effectiveness research

European Urology

Volumn 67, Issue 6, 2015, Pages 1019-1025

  Resnick, Matthew J ^a,b   Barocas, Daniel A ^a   Morgans, Alicia K ^c   Phillips, Sharon E ^c   Koyama, Tatsuki ^c   Albertsen, Peter C ^d   Cooperberg, Matthew R ^e   Goodman, Michael ^f   Greenfield, Sheldon ^g   Hamilton, Ann S ^h   Hoffman, Karen E ⁱ   Hoffman, Richard M ^j   Kaplan, Sherrie H ^g   McCollum, Dan ^c   Paddock, Lisa E ^k   Stanford, Janet L ^l   Stroup, Antoinette M ^k   Wu, Xiao Cheng ^m   Penson, David F ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f EMORY UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j UNIVERSITY OF NEW MEXICO   (United States)

^k New Jersey State Cancer Registry   (United States)

^l Fred Hutchinson Cancer Research Center   (United States)

^m LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

more..

Author keywords

Patient reported outcomes; Prostate cancer; Quality of life; Sexual function; Urinary function

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONSUMER; ERECTILE DYSFUNCTION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MARKETING; MEDICAL RESEARCH; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SOCIAL NORM; URINARY DYSFUNCTION; URINE INCONTINENCE; ADVERSE EFFECTS; INCIDENCE; PROCEDURES; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME; URINARY INCONTINENCE;

ADULT; AGED; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; ERECTILE DYSFUNCTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; REGRESSION ANALYSIS; RISK FACTORS; SELF REPORT; TIME FACTORS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 84929037327     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.035     Document Type: Article

References (30)

1. J.M. Donohue, M. Cevasco, and M.B. Rosenthal A decade of direct-to-consumer advertising of prescription drugs N Engl J Med 357 2007 673 681
2. A.L. Potosky, B.B. Reeve, and L.X. Clegg Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy J Natl Cancer Inst 94 2002 430 437
3. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
4. M.J. Resnick, T. Koyama, and K.H. Fan Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
5. S. An, and H. Kang Stigma-reducing components in direct-to-consumer prescription ads: onset controllability, offset controllability, and recategorization Health Commun 26 2011 468 478
6. J.A. Sirey, M.L. Bruce, G.S. Alexopoulos, D.A. Perlick, S.J. Friedman, and B.S. Meyers Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence Psychiatr Serv 52 2001 1615 1620
7. A.L. Potosky, L.C. Harlan, and J.L. Stanford Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study J Natl Cancer Inst 91 1999 1719 1724
8. A.L. Potosky, J. Legler, and P.C. Albertsen Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study J Natl Cancer Inst 92 2000 1582 1592
9. J. Legler, A.L. Potosky, F.D. Gilliland, J.W. Eley, and J.L. Stanford Validation study of retrospective recall of disease-targeted function: results from the Prostate Cancer Outcomes Study Med Care 38 2000 847 857
10. D.P. Lubeck, M.S. Litwin, and J.M. Henning The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor Urology 48 1996 773 777
11. D.A. Barocas, V. Chen, and M. Cooperberg Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study J Comp Eff Res 2 2013 445 460
12. M.S. Litwin, R.D. Hays, A. Fink, P.A. Ganz, B. Leake, and R.H. Brook The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002 1012
13. K.M. Szymanski, J.T. Wei, R.L. Dunn, and M.G. Sanda Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors Urology 76 2010 1245 1250
14. J.I. Epstein, W.C. Allsbrook, M.B. Amin, L.L. Egevad ISUP Grading Committee The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
15. D.L. Frosch, D. Grande, D.M. Tarn, and R.L. Kravitz A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising Am J Public Health 100 2010 24 32
16. D.S. Freedman Centers for Disease Control and Prevention (CDC) Obesity - United States, 1988-2008 MMWR Surveill Summ 60 Suppl 2011 73 77
17. J.M. Donohue, E.R. Berndt, M. Rosenthal, A.M. Epstein, and R.G. Frank Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression Med Care 42 2004 1176 1185
18. R.L. Kravitz, R.M. Epstein, and M.D. Feldman Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial [published correction appears in JAMA 2005;294:2436] JAMA 293 2005 1995 2002
19. P. Conrad, and V. Leiter Medicalization, markets and consumers J Health Soc Behav Suppl 2004 158 176
20. Centers for Disease Control and Prevention (CDC) Increasing prevalence of diagnosed diabetes - United States and Puerto Rico, 1995-2010 MMWR Morb Mortal Wkly Rep 61 2012 918 921
21. C.S. Saigal, H. Wessells, J. Pace, M. Schonlau, and T.J. Wilt Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population Arch Intern Med 166 2006 207 212
22. A.D. Seftel, P. Sun, and R. Swindle The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction J Urol 171 2004 2341 2345
23. S.N. Bonaccorso, and J.L. Sturchio For and against: direct to consumer advertising is medicalising normal human experience: Against BMJ 324 2002 910 911
24. R.K. Lee, D. Chung, B. Chughtai, A.E. Te, and S.A. Kaplan Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms BJU Int 110 2012 540 545
25. B. Mintzes For and against: Direct to consumer advertising is medicalising normal human experience: For BMJ 324 2002 908 909
26. A.F. Holmer Direct-to-consumer advertising - strengthening our health care system N Engl J Med 346 2002 526 528
27. B.G. Link, and J.C. Phelan Conceptualizing stigma Annu Rev Sociol 27 2001 363 385
28. P. Cram, A.M. Fendrick, J. Inadomi, M.E. Cowen, D. Carpenter, and S. Vijan The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect Arch Intern Med 163 2003 1601 1605
29. A.B. Nattinger, R.G. Hoffmann, A. Howell-Pelz, and J.S. Goodwin Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women JAMA 279 1998 762 768
30. V.A. Moyer U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120 134